Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Marina Biotech Inc

+ Add to Watchlist

MRNA:US

0.4700 USD 0.0003 0.06%

As of 20:10:08 ET on 06/01/2015.

Snapshot for Marina Biotech Inc (MRNA)

Open: 0.4703 Day's Range: 0.4650 - 0.5100 Volume: 110,955
Previous Close: 0.4703 52wk Range: 0.4650 - 1.3000 1-Yr Rtn: -27.47%

Stock Chart for MRNA

No chart data available.
  • MRNA:US 0.4770
  • 1D
  • 1M
  • 1Y
0.4703
Interactive MRNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRNA

Current P/E Ratio (ttm) 2.9375
Estimated P/E(12/2015) -
Relative P/E vs. SPX 0.1576
Earnings Per Share (USD) (ttm) 0.1600
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 12.05
Shares Outstanding (M) 25.64
30 Day Average Volume 38,189
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRNA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MRNA

Marina Biotech, Inc. is a biopharmaceutical company. The Company researches and develops therapies for inflammatory diseases and cancer using ribonucleic acid chemistry.

J Michael FrenchChairman/President/CEODaniel E Geffken "Dan"Interim CFO
More Company Profile & Key Executives for MRNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil